Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis - Kondo, Masahiro; Suzuki, Tsuyoshi; Kawano, Yuko; Kojima, Shinji; Miyashiro, Masahiko; Matsumoto, Atsuhiro; Kania, Gabriela; Błyszczuk, Przemysław; Ross, Rebecca L.; Mulipa, Panji; Galdo, Francesco Del; Zhang, Yun; et al. (Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023)